Commercial Insight Inflammatory Bowel Disease Convenience and compliance drive market success

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Non-Insulin Diabetes Management: Products, Players, Markets and Forecasts

Non-Insulin Diabetes Management: Products, Players, Markets and Forecasts

  • $ 3 850
  • Industry report
  • by Greystone Research Associates
  • May 2012

The diabetes market is changing. The convergence of environmental factors, lifestyle factors and increased patient longevity are driving double-digit growth projections for the incidence of non-insulin dependent (Type 2) diabetes globally. Type 2 diabetes accounts for about 90% of all diagnosed cases ...

Industries: Drug and Medication | Countries: Japan, Europe

Mitsubishi Tanabe Pharma Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Mitsubishi Tanabe Pharma Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • by ICD Research
  • May 2012
  • 46 pages

Synopsis ICD Research's "Mitsubishi Tanabe Pharma Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, ...

Industries: Pharmaceutical | Countries: Japan

Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • by ICD Research
  • May 2012
  • 47 pages

Synopsis ICD Research's "Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, ...

Industries: Prescription Drug | Countries: Japan

Bladder Cancer - Executive Market Summary 2011

Bladder Cancer - Executive Market Summary 2011

  • $ 995
  • Industry report
  • by Timely Data Resources, Inc.
  • May 2012
  • 16 pages

Abstract TheBladder Cancer Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information ...

Industries: Pathology | Countries: World, Russian Federation, Philippines, Europe, Mexico, Canada, Spain, Italy, France, Germany, Japan, India, China, Argentina, South Africa, Asia, Brazil, Sweden, Poland, Greece, Thailand, Egypt, Africa, United States, United Kingdom, South America, North America

Colorectal Cancer - Executive Market Summary 2011

Colorectal Cancer - Executive Market Summary 2011

  • $ 995
  • Industry report
  • by Timely Data Resources, Inc.
  • May 2012
  • 18 pages

Abstract The Colorectal Cancer Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, information on diagnosis, staging, and prognosis, and an overview of treatment. Dosing ...

Industries: Pathology | Countries: World, Europe, Russian Federation, Philippines, Mexico, Canada, Sweden, Spain, Italy, France, Germany, Finland, Japan, India, China, Africa, Argentina, South Africa, Asia, Brazil, Poland, Greece, Thailand, Egypt, United States, United Kingdom, South America, Netherlands, Colombia, Denmark, Nigeria, Kenya, North America

Chronic Obstructive Pulmonary Disease (COPD) - Executive Market Summary 2011

Chronic Obstructive Pulmonary Disease (COPD) - Executive Market Summary 2011

  • $ 995
  • Industry report
  • by Timely Data Resources, Inc.
  • May 2012
  • 16 pages

Abstract The Chronic Obstructive Pulmonary Disease (COPD) Executive Market Summary 2011 provides an overview of the disease and related conditions, with prevalence and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and ...

Industries: Pathology | Countries: World, Europe, France, China, Australia, United States, Mexico, Canada, United Kingdom, Sweden, Spain, Russian Federation, Romania, Poland, Italy, Greece, Germany, Japan, India

Ulcerative Colitis - Executive Market Summary 2011

Ulcerative Colitis - Executive Market Summary 2011

  • $ 995
  • Industry report
  • by Timely Data Resources, Inc.
  • May 2012
  • 18 pages

Abstract The Ulcerative Colitis Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence prevalence information for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided fo ...

Industries: Pathology | Countries: South Korea, World, Canada, Italy, Japan, Europe, North America, Australia, Singapore, United States, United Kingdom, Spain, France, Germany, China, Asia

Drug and Medication in United States: Gilead Sciences, Inc. ? Product Pipeline Review - H2 2011

Drug and Medication in United States: Gilead Sciences, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 261 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Gilead Sciences, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data ...

Industries: Drug and Medication | Countries: Japan, United States

Insulin - Top 5 Asian Markets

Insulin - Top 5 Asian Markets

  • $ 2 514
  • Industry report
  • by Global Research & Data Services
  • May 2012

This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 Asian markets. The analyses provide essential market information for decision-makers including: China, Japan, India, South Korea and Indonesia   * Overall ...

Industries: Drug and Medication | Countries: Asia, South Korea, Indonesia, Japan, India, China, World

Insulin - Japan

Insulin - Japan

  • $ 652
  • Industry report
  • by Global Research & Data Services
  • May 2012
  • 31 pages

This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in Japan. The study provides essential market information for decision-makers including: Overall market value for insulin in Japan Overall market volume for insulin in Japan ...

Industries: Drug and Medication | Countries: Japan

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 618 48 97

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.